Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹14,549Cr
Rev Gr TTM
Revenue Growth TTM
17.37%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

NIVABUPA
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | 42.5 | 33.8 | | 30.0 | 36.1 | 37.1 | 20.1 | 18.6 | 12.9 | 13.1 | 24.9 |
| 870 | 865 | 969 | 1,021 | 1,152 | 1,136 | 1,301 | 1,237 | 1,470 | 1,454 | 1,600 | 1,685 |
Operating Profit Operating ProfitCr |
| 14.2 | -1.6 | 2.3 | 1.1 | 12.6 | 2.0 | 4.3 | 0.3 | 6.1 | -11.1 | -4.0 | -8.8 |
Other Income Other IncomeCr | 117 | 172 | 189 | 230 | 304 | 277 | 320 | 315 | 357 | 324 | 334 | 386 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 39 | -72 | -8 | 5 | 157 | -19 | 13 | 13 | 206 | -91 | -35 | -88 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | -2,363.3 | -403.6 | | 302.2 | 73.9 | 271.5 | 189.1 | 31.2 | -385.9 | -370.9 | -761.9 |
| 3.9 | -8.5 | -0.8 | 0.4 | 11.9 | -1.6 | 1.0 | 1.1 | 13.2 | -7.0 | -2.3 | -5.7 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 1.1 | -0.5 | -0.2 | -0.5 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 49.7 | 32.7 | 26.9 | 11.9 |
| 2,923 | 3,991 | 5,015 | 6,227 | 6,209 |
Operating Profit Operating ProfitCr |
| -38.4 | -26.2 | -19.5 | -17.0 | -4.2 |
Other Income Other IncomeCr | 0 | 364 | 218 | 142 | 1,400 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 |
| -197 | 13 | 82 | 214 | -8 |
| 0 | 0 | 0 | 0 | 0 |
|
| | 106.4 | 552.7 | 160.9 | -103.9 |
| -9.3 | 0.4 | 1.9 | 4.0 | -0.1 |
| -1.4 | 0.1 | 0.5 | 1.2 | 0.0 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
|---|
Equity Capital Equity CapitalCr | 1,409 | 1,511 | 1,700 | 1,827 | 0 |
| -903 | -683 | 1,283 | 1,949 | 0 |
| 250 | 250 | 250 | 250 | 0 |
Other Liabilities Other LiabilitiesCr | 0 | 0 | -932 | -718 | 0 |
|
Fixed Assets Fixed AssetsCr | | | 59 | 75 | 0 |
| 229 | 353 | 532 | 1,289 | |
Cash Equivalents Cash EquivalentsCr | 59 | 102 | 143 | 220 | 0 |
Other Assets Other AssetsCr | 468 | 623 | 1,567 | 1,723 | 0 |
|
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 338 | 593 | 813 | 1,654 |
Investing Cash Flow Investing Cash FlowCr | -723 | -829 | -1,882 | -2,348 |
Financing Cash Flow Financing Cash FlowCr | 374 | 280 | 1,110 | 771 |
|
Free Cash Flow Free Cash FlowCr | 309 | 555 | 780 | 1,613 |
| -171.9 | 4,724.6 | 992.9 | 774.7 |
CFO To EBITDA CFO To EBITDA% | -41.6 | -71.5 | -99.2 | -183.2 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 14,253 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 66.7 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 2.6 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 4.7 |
| -0.2 | -0.2 | -0.1 | -15.8 |
Profitability Ratios Profitability Ratios |
| -38.4 | -26.2 | -19.5 | -17.0 |
| -9.3 | 0.4 | 1.9 | 4.0 |
| -26.0 | 1.2 | 2.5 | 5.3 |
| -38.9 | 1.5 | 2.7 | 5.7 |
| -26.0 | 1.2 | 3.6 | 6.5 |
Solvency Ratios Solvency Ratios |
Niva Bupa Health Insurance Company Limited (formerly Max Bupa) is a premier standalone health insurer (SAHI) in India. Operating as a subsidiary of **Bupa Singapore Holdings Pte Ltd** (holding **55.36%**), the company has transitioned from a high-growth startup phase into a scaled, profitable enterprise. As the **3rd largest retail health insurer** in India, Niva Bupa commands a **10.2% retail market share** (as of **Q3 FY26**) and is a primary beneficiary of India’s under-penetrated health insurance sector.
---
### **Strategic Market Positioning & Product Architecture**
Niva Bupa employs a data-driven, customer-centric strategy focused on **Lifetime Value (LTV)**. Its product suite is segmented to capture the entire demographic spectrum of the Indian market:
* **The Flagship "ReAssure" Series:**
* **ReAssure 2.0 & 3.0:** Features "Lock the Clock" (premiums fixed to entry age until a claim is made) and "ReAssure Forever" (unlimited base sum restoration).
* **ReAssure 3.0 Innovations:** Includes **Wellconsult+** (OPD benefits up to **₹1 Lakh**) and **Safeguard+** (coverage for non-payable medical items).
* **High-Net-Worth (HNI) Segment:** **Health Premia** and **NivaBupaOne** offer coverage up to **₹5 Crores** with international coverage for major illnesses and significant OPD limits.
* **The "Missing Middle" & Rural Expansion:** The **Rise** product (launched **Feb 2025**) targets Tier III/IV cities with **Flexi-Pay** monthly installments and a **50% Premium Return** feature.
* **Next-Gen & Specialized Coverage:**
* **Aspire/Elixir:** Targets Millennials/Gen Z with **M-iracle** (covering maternity, IVF, and adoption) and **Cash-bag** rewards.
* **Senior First:** Tailored for senior citizens with an industry-first **2-hour hospitalization** feature.
---
### **Omni-Channel Distribution & Network Scale**
The company utilizes a "new store" and "same-store" sales approach to maintain a retail business **CAGR target of 17%-18%**.
| Channel | Scale & Reach (as of 9M FY26) |
| :--- | :--- |
| **Individual Agents** | **224,810** agents; added **15,000** in **Q3 FY26** alone. |
| **Bancassurance** | **116** partners, including **HDFC Bank, Axis Bank, and Bank of Baroda**. |
| **Brokers** | **575+** partners, including major digital platforms like **PolicyBazaar**. |
| **Physical Footprint** | **210+** branches and **400+** locations across India. |
| **Direct-to-Consumer** | Contributes **10-13%** of total business. |
**Provider Network:** Niva Bupa manages medical inflation through a **Preferred Partner Network (PPN)** active in **43** cities across **~600** hospitals, offering ambulance services and relationship managers. The total empanelled network exceeds **10,587** hospitals.
---
### **Digital Ecosystem & "Intelligent Automation"**
Niva Bupa is transitioning from a traditional insurer to a "health partner" through its **Niva Bupa Health App** (**1.23 crore+ downloads**; **5.7 lakh MAU**).
* **Underwriting & Issuance:** **99.9%** of new policies are digital; **51%** of retail policies are auto-decisioned via rule-based engines.
* **Claims Revolution:** **28.6%** of cashless claims are processed via **Auto-Adjudication**, reducing pre-authorization time from **30 minutes** to under **2 minutes**.
* **Renewals:** **91.6%** of renewals are completed without human intervention.
* **Health Services:** The app facilitates **6,000+** monthly doctor consults and **50,000+** monthly health checkups.
---
### **Financial Performance & Operational Metrics**
The company listed in **November 2024**, raising **₹2,200 crore** (including **₹800 crore** fresh issue) to bolster solvency.
**Key Financial Indicators (9M FY26 vs. 9M FY25 - IFRS):**
* **Gross Written Premium (GWP):** **₹5,706 Cr** (Reported) / **₹6,309 Cr** (Like-to-Like, **+25.9%**).
* **Profit After Tax (PAT):** **₹208 Cr** (up **74%** YoY).
* **Combined Ratio (COR):** Improved to **102.9%** (down **50 bps**).
* **Solvency Ratio:** Robust at **3.03x** (as of March 2025), well above the **1.50x** mandate.
* **Expense of Management (EOM):** Improved to **35%** from **39%** YoY.
**Accounting Note:** Effective **Oct 1, 2024**, the company adopted **1/n accounting**, recognizing premiums proportionately over the policy duration. This resulted in a technical decrease in reported GWP of **₹644.5 Cr** for FY25 but does not impact underlying cash flows.
---
### **Regulatory Tailwinds & Industry Catalysts**
* **GST Reform:** The reduction of GST on retail health insurance from **18% to 0%** (late 2025) is a "secular win." Niva Bupa observed a **15% increase in retail ticket size** as customers reinvested tax savings into higher sum insured plans.
* **Bima Sugam:** The company invested **₹5.00 Cr** in this centralized digital marketplace to drive long-term penetration.
* **FDI & Licensing:** Proposed **100% FDI** and **Composite Licenses** may allow for future capital inflows and multi-line expansion.
---
### **Risk Factors & Mitigation Framework**
Niva Bupa operates under a **three lines of defence** model to manage the following:
* **Regulatory Compliance:** The company has historically exceeded **EOM** limits (**39.22%** vs **35.55%** limit in FY25). Forbearance for the most recent year is pending. A **Show Cause Notice** was issued by IRDAI in **Feb 2026** regarding operational aspects.
* **Tax Litigations:** Significant outstanding demands exist, including **₹127.16 Cr** in Income Tax (AY 2020-24) and a remanded **₹124.13 Cr** GST case regarding co-insurance commissions.
* **Medical Inflation:** Retail claim costs have a **7.0% CAGR** since FY19. The company mitigates this through periodic price revisions (e.g., **7%** hike on ReAssure 2.0 in **Q1 FY26**).
* **Cybersecurity:** Following threats in late 2024 and early 2025, the company has implemented independent impact assessments and enhanced data security protocols.
* **Labor Costs:** Implementation of **New Labour Codes** in **Nov 2025** added a one-time cost of **₹19.92 Cr** for gratuity and leave encashment.